Fig. 4From: New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationIncremental costs by year until 2050 for the Basecase M72/AS01E and BCG-revaccination scenarios compared to the Status Quo no-new-vaccine baseline. USD$, United States dollarsBack to article page